GLP-1 drugs glucagon-like peptide-1 receptor agonists like Wegovy and Mounjaro have taken the world by storm
For patients in Doral and the greater Miami area researching peptides, understanding that distinction is the most important takeaway
Reduced Cardiovascular Events and Improved Health: GLP-1 users experienced a 44 percent reduction in risk of hospitalizations caused by major adverse cardiovascular events (e.g., stroke, heart attack and heart failure) over the 24 months following therapy initiation
Tracy Norfleet, MD, FACP, notes: "Injection site reactions may get worse over the first 24 hours, and should improve thereafter
Role of ERK1/2 in the differential synthesis of progesterone and estradiol by granulosa cells
$48 billion in new Medicare spending over 10 years